Press Contact
For media enquiries, please reach out to: contact@aspivix.com

All
  • All
  • Blog
  • In the media
  • Press releases

Bayer (Schweiz) AG and ASPIVIX collaborate to reduce pain in Women’s Health procedures

Epalinges, Switzerland – April 15, 2024 - ASPIVIX announces its partnership with Bayer (Schweiz) AG in Switzerland, aimed at transforming gynecological procedures.Together, we are introducing Carevix®, a CE-Marked cervical stabilizer designed to...
Read More about Bayer (Schweiz) AG and ASPIVIX collaborate to reduce pain in Women’s Health procedures

ASPIVIX and Bayer Switzerland Collaborate to Reduce Pain in Women’s Health Procedures Including IUDs

Women's health medtech company ASPIVIX has recenlty joined forces with Bayer Switzerland to introduce carevix®, a cervical stabilizer designed to minimize pain and bleeding during transcervical procedures, including IUD placement. This collaboration combines Bayer's...
Read More about ASPIVIX and Bayer Switzerland Collaborate to Reduce Pain in Women’s Health Procedures Including IUDs

The first successful painless IUD and transcervical procedures performed with the Carevix® in Indianapolis, US enhancing Women’s Care in gynecology

Epalinges, Switzerland – March 15, 2024. We are thrilled to announce a groundbreaking achievement in the United States with the first patients benefiting from successful painless IUD placement and transcervical procedures using...
Read More about The first successful painless IUD and transcervical procedures performed with the Carevix® in Indianapolis, US enhancing Women’s Care in gynecology

ASPIVIX Receives CE Mark Approval for Carevix®

ASPIVIX Receives CE Mark Approval for Carevix® to Reduce Pain During IUD and Transcervical Procedures, Expanding Collaboration with Ambassadors Worldwide and Enhancing Women’s Health Without Fear of Pain. Epalinges, Switzerland – December...
Read More about ASPIVIX Receives CE Mark Approval for Carevix®

Welcoming Excellence to Aspivix’s Board: Dr. Susan Nicholson and Jessica J. Federer

Epalinges, Switzerland – December 11, 2023 – Dr. Susan Nicholson & Jessica J. Federer join Aspivix's Board of Directors alongside Keren Leshem, fortifying the Company’s Leadership in Women's Health Care Innovation. At...
Read More about Welcoming Excellence to Aspivix’s Board: Dr. Susan Nicholson and Jessica J. Federer

Aspivix CEO Mathieu Horras Discusses How Much IUD Insertion Can Hurt Less on X-Health.show

Renens, Switzerland - 3 October 2023 - Mathieu Horras, CEO of Aspivix, recently joined Alex Jani on the X-Health.show podcast to delve into pressing issues and innovations in women's healthcare concerning IUD...
Read More about Aspivix CEO Mathieu Horras Discusses How Much IUD Insertion Can Hurt Less on X-Health.show